½ÃÀ庸°í¼­
»óǰÄÚµå
1238716

Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå : ±âȸ ¹× Àü·«(-2032³â)

Community Oncology Services Global Market Opportunities And Strategies To 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 356 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Business Research CompanyÀÇ 'Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º(Community Oncology Services) ½ÃÀå : ±âȸ ¹× Àü·«(-2032³â)'Àº Àü·«°¡, ¸¶ÄÉÆÃ ´ã´çÀÚ, ¼ö¼® °ü¸®ÀÚ¿¡°Ô COVID-19 ¶ô´Ù¿î¿¡¼­ ÀϾ´Â ¼¼°èÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀåÀ» Æò°¡ Çϱâ À§ÇØ ÇÊ¿äÇÑ Áß¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º °ü·Ã °¡Àå Å©°í ±Þ¼ºÀåÇÏ´Â ½ÃÀåÀº ¾îµðÀΰ¡? ÀÌ ½ÃÀåÀº Àüü °æÁ¦, Àα¸ µ¿Çâ ¹× ±âŸ À¯»çÇÑ ½ÃÀå°ú ¾î¶»°Ô °ü·ÃµÇ¾î Àִ°¡? ÇâÈÄ ½ÃÀåÀ» Çü¼ºÇÏ´Â ÈûÀº? ºñÁî´Ï½º ¸®¼­Ä¡ ȸ»çÀÇ 'Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå º¸°í¼­ '´Â ÀÌ·¯ÇÑ ¸ðµç Áú¹®°ú ´Ù¸¥ ¸¹Àº Áú¹®¿¡ ´äº¯ÇÕ´Ï´Ù.

½ÃÀåÀÇ Æ¯Â¡, ±Ô¸ð¿Í ¼ºÀå, ¼¼ºÐÈ­, Áö¿ª¡¤±¹°¡, °æÀï »óȲ, ½ÃÀå Á¡À¯À², Æ®·»µå, Àü·«¿¡ ´ëÇØ ¼³¸íÇÕ´Ï´Ù. ½ÃÀåÀÇ ¿ª»ç¸¦ µû¶ó Áö¿ªº° ½ÃÀå ¼ºÀåÀ» ¿¹ÃøÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÌ ½ÃÀåÀ» º¸´Ù ±¤¹üÀ§ÇÑ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀåÀÇ ¸Æ¶ô¿¡ À§Ä¡½Ã۰í, ´Ù¸¥ ½ÃÀå°úÀÇ ºñ±³µµ ½Ç½ÃÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¸ñÂ÷

Á¦3Àå ±×¸² ¸ñ·Ï

Á¦4Àå Å×ÀÌºí ¸ñ·Ï

Á¦5Àå º¸°í¼­ ±¸Á¶

Á¦6Àå ½ÃÀå ¼Ò°³ ¹× Ư¡

  • ÀϹÝÀûÀÎ ½ÃÀå Á¤ÀÇ
  • Á¤¸®
  • Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå Á¤ÀÇ ¹× ¼¼ºÐÈ­
  • À¯Çüº° ½ÃÀå ¼¼ºÐÈ­
    • ¼Ò±Ô¸ð Ä¿¹Â´ÏƼ Á¾¾çÇРŬ¸®´Ð
    • Áß±Ô¸ð Ä¿¹Â´ÏƼ Á¾¾çÇРŬ¸®´Ð
    • ´ë±Ô¸ð Ä¿¹Â´ÏƼ Á¾¾çÇРŬ¸®´Ð
  • ¾Ï Á¾·ùº° ½ÃÀå ¼¼ºÐÈ­
    • À¯¹æ¾Ï
    • Æó¾Ï
    • ½ÅÀå¾Ï
    • ³­¼Ò¾Ï
    • Àü¸³¼±¾Ï
    • ÇǺξÏ
    • ÃéÀå¾Ï
    • Ç÷¾×¾Ï
    • ´ëÀå¾Ï
    • ±âŸ ¾Ï Á¾·ù
  • Ä¡·á À¯Çüº° ½ÃÀå ¼¼ºÐÈ­
    • Á¾¾ç³»°ú
    • ¹æ»ç¼± Á¾¾çÇÐ
    • ¿Ü°ú Á¾¾çÇÐ
    • ±âŸ Ä¡·á À¯Çü

Á¦7Àå ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ¿ø°Ý ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ÁÖ·Â
  • ÅõÀÚ Áõ°¡
  • ÆÄÆ®³Ê½Ê°ú Çù¾÷
  • °³º° ¼­ºñ½º Ç÷£
  • ±â¼úÀÇ Áøº¸
  • ÇÕº´°ú Àμö

Á¦8Àå ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

  • ½ÃÀå ±Ô¸ð
  • ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
    • ½ÃÀå ÃËÁø ¿äÀÎ(2017-2022³â)
    • ½ÃÀå ¾ïÁ¦ ¿äÀÎ(2017-2022³â)
  • ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
    • ½ÃÀå ÃËÁø ¿äÀÎ(2022-2027³â)
    • ½ÃÀå ¾ïÁ¦ ¿äÀÎ(2022-2027³â)

Á¦9Àå ¼¼°èÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¼¼°èÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¼¼°èÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)

Á¦10Àå Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Áö¿ª ¹× ±¹°¡ ºÐ¼®

  • ¼¼°èÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Áö¿ªº°, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¼¼°èÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ±¹°¡º°, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)

Á¦11Àå ¾Æ½Ã¾Æ ÅÂÆò¾ç ½ÃÀå

  • Á¤¸®
  • ½ÃÀå °³¿ä
    • Áö¿ª Á¤º¸
    • ½ÃÀå Á¤º¸
    • ¹è°æ Á¤º¸
    • Á¤ºÎÀÇ ´ëó
    • ±ÔÁ¤
    • ±ÔÁ¦ ±â°ü
    • ÁÖ¿ä Çùȸ
    • ¡¼ö¼¼¾×
    • ¹ýÀμ¼ÀÇ ±¸Á¶
    • ÅõÀÚ
    • ÁÖ¿ä ±â¾÷
  • ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå : ±¹°¡º° ºÐ¼®
  • Áß±¹ ½ÃÀå
  • Á¤¸®
  • ½ÃÀå °³¿ä
    • ±¹°¡º° Á¤º¸
    • ½ÃÀå Á¤º¸
    • ¹è°æ Á¤º¸
    • Á¤ºÎÀÇ ´ëó
    • ±ÔÁ¤
    • ±ÔÁ¦ ±â°ü
    • ÁÖ¿ä Çùȸ
    • ¡¼ö¼¼¾×
    • ¹ýÀμ¼ÀÇ ±¸Á¶
    • ÅõÀÚ
    • ÁÖ¿ä ±â¾÷
  • Áß±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • Áß±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • Áß±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • Áß±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • Áß±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • Àεµ ½ÃÀå
  • ÀεµÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • ÀεµÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • ÀεµÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ÀεµÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ÀεµÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ÀϺ»ÀÇ ½ÃÀå
  • ÀϺ»ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • ÀϺ»ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • ÀϺ»ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ÀϺ»ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ÀϺ»ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • È£ÁÖÀÇ ½ÃÀå
  • È£ÁÖÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • È£ÁÖÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • È£ÁÖÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • È£ÁÖÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • È£ÁÖÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • Àεµ³×½Ã¾ÆÀÇ ½ÃÀå
  • Àεµ³×½Ã¾ÆÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • Àεµ³×½Ã¾ÆÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • Àεµ³×½Ã¾ÆÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • Àεµ³×½Ã¾ÆÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • Àεµ³×½Ã¾ÆÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • Çѱ¹ÀÇ ½ÃÀå
  • Çѱ¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • Çѱ¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • Çѱ¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • Çѱ¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • Çѱ¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)

Á¦12Àå ¼­À¯·´ ½ÃÀå

  • Á¤¸®
  • ½ÃÀå °³¿ä
    • Áö¿ª Á¤º¸
    • ½ÃÀå Á¤º¸
    • ¹è°æ Á¤º¸
    • Á¤ºÎÀÇ ´ëó
    • ±ÔÁ¤
    • ±ÔÁ¦ ±â°ü
    • ÁÖ¿ä Çùȸ
    • ¡¼ö¼¼¾×
    • ¹ýÀμ¼ÀÇ ±¸Á¶
    • ÅõÀÚ
    • ÁÖ¿ä ±â¾÷
  • ¼­À¯·´ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • ¼­À¯·´ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • ¼­À¯·´ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¼­À¯·´ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¼­À¯·´ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¼­À¯·´ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå : ±¹°¡º° ºÐ¼®
  • ¿µ±¹ÀÇ ½ÃÀå
  • ¿µ±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • ¿µ±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • ¿µ±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¿µ±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¿µ±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • µ¶ÀÏÀÇ ½ÃÀå
  • µ¶ÀÏÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • µ¶ÀÏÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • µ¶ÀÏÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • µ¶ÀÏÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • µ¶ÀÏÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ÇÁ¶û½ºÀÇ ½ÃÀå
  • ÇÁ¶û½ºÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • ÇÁ¶û½ºÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • ÇÁ¶û½ºÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ÇÁ¶û½ºÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ÇÁ¶û½ºÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)

Á¦13Àå µ¿À¯·´ ½ÃÀå

  • Á¤¸®
  • ½ÃÀå °³¿ä
    • Áö¿ª Á¤º¸
    • ½ÃÀå Á¤º¸
    • ¹è°æ Á¤º¸
    • Á¤ºÎÀÇ ´ëó
    • ±ÔÁ¤
    • ±ÔÁ¦ ±â°ü
    • ÁÖ¿ä Çùȸ
    • ¡¼ö¼¼¾×
    • ¹ýÀμ¼ÀÇ ±¸Á¶
    • ÅõÀÚ
    • ÁÖ¿ä ±â¾÷
  • µ¿À¯·´ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • µ¿À¯·´ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • µ¿À¯·´ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • µ¿À¯·´ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • µ¿À¯·´ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • µ¿À¯·´ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå : ±¹°¡º° ºÐ¼®
  • ·¯½Ã¾ÆÀÇ ½ÃÀå
  • ·¯½Ã¾ÆÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • ·¯½Ã¾ÆÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • ·¯½Ã¾ÆÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ·¯½Ã¾ÆÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ·¯½Ã¾ÆÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)

Á¦14Àå ºÏ¹Ì ½ÃÀå

  • Á¤¸®
  • ½ÃÀå °³¿ä
    • Áö¿ª Á¤º¸
    • ½ÃÀå Á¤º¸
    • ¹è°æ Á¤º¸
    • Á¤ºÎÀÇ ´ëó
    • ±ÔÁ¤
    • ±ÔÁ¦ ±â°ü
    • ÁÖ¿ä Çùȸ
    • ¡¼ö¼¼¾×
    • ¹ýÀμ¼ÀÇ ±¸Á¶
    • ÅõÀÚ
    • ÁÖ¿ä ±â¾÷
  • ºÏ¹ÌÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • ºÏ¹ÌÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • ºÏ¹ÌÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ºÏ¹ÌÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ºÏ¹ÌÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ºÏ¹ÌÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå : ±¹°¡º° ºÐ¼®
  • ¹Ì±¹ ½ÃÀå
  • Á¤¸®
  • ½ÃÀå °³¿ä
    • ±¹°¡º° Á¤º¸
    • ½ÃÀå Á¤º¸
    • ¹è°æ Á¤º¸
    • Á¤ºÎÀÇ ´ëó
    • ±ÔÁ¤
    • ±ÔÁ¦ ±â°ü
    • ÁÖ¿ä Çùȸ
    • ¡¼ö¼¼¾×
    • ¹ýÀμ¼ÀÇ ±¸Á¶
    • ÅõÀÚ
    • ÁÖ¿ä ±â¾÷
  • ¹Ì±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • ¹Ì±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • ¹Ì±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¹Ì±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¹Ì±¹ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)

Á¦15Àå ³²¹Ì ½ÃÀå

  • Á¤¸®
  • ½ÃÀå °³¿ä
    • Áö¿ª Á¤º¸
    • ½ÃÀå Á¤º¸
    • ¹è°æ Á¤º¸
    • Á¤ºÎÀÇ ´ëó
    • ±ÔÁ¤
    • ±ÔÁ¦ ±â°ü
    • ÁÖ¿ä Çùȸ
    • ¡¼ö¼¼¾×
    • ¹ýÀμ¼ÀÇ ±¸Á¶
    • ÅõÀÚ
    • ÁÖ¿ä ±â¾÷
  • ³²¹ÌÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • ³²¹ÌÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • ³²¹ÌÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ³²¹ÌÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ³²¹ÌÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ³²¹ÌÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå : ±¹°¡º° ºÐ¼®
  • ºê¶óÁúÀÇ ½ÃÀå
  • ºê¶óÁúÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • ºê¶óÁúÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • ºê¶óÁúÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ºê¶óÁúÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ºê¶óÁúÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)

Á¦16Àå Áßµ¿ ½ÃÀå

  • Á¤¸®
  • ½ÃÀå °³¿ä
    • Áö¿ª Á¤º¸
    • ½ÃÀå Á¤º¸
    • ¹è°æ Á¤º¸
    • Á¤ºÎÀÇ ´ëó
    • ±ÔÁ¤
    • ±ÔÁ¦ ±â°ü
    • ÁÖ¿ä Çùȸ
    • ¡¼ö¼¼¾×
    • ¹ýÀμ¼ÀÇ ±¸Á¶
    • ÅõÀÚ
    • ÁÖ¿ä ±â¾÷
  • Áßµ¿ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • Áßµ¿ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • Áßµ¿ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • Áßµ¿ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • Áßµ¿ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)

Á¦17Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

  • Á¤¸®
  • ½ÃÀå °³¿ä
    • Áö¿ª Á¤º¸
    • ½ÃÀå Á¤º¸
    • ¹è°æ Á¤º¸
    • Á¤ºÎÀÇ ´ëó
    • ±ÔÁ¤
    • ±ÔÁ¦ ±â°ü
    • ÁÖ¿ä Çùȸ
    • ¡¼ö¼¼¾×
    • ¹ýÀμ¼ÀÇ ±¸Á¶
    • ÅõÀÚ
    • ÁÖ¿ä ±â¾÷
  • ¾ÆÇÁ¸®Ä«ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ½ÇÀû(2017-2022³â)
  • ¾ÆÇÁ¸®Ä«ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ½ÃÀå ¼ºÀå ¿¹Ãø(2022-2027³â, 2032³â)
  • ¾ÆÇÁ¸®Ä«ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¾ÆÇÁ¸®Ä«ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, ¾Ï Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)
  • ¾ÆÇÁ¸®Ä«ÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, Ä¡·á À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2027³â, 2032³â)

Á¦18Àå °æÀï »óȲ ¹× ±â¾÷ °³¿ä

  • ±â¾÷ °³¿ä
  • The US Oncology Network
    • ±â¾÷ °³¿ä
    • Á¦Ç° ¹× ¼­ºñ½º
    • »ç¾÷ Àü·«
    • À繫 ½ÇÀû
  • OneOncology
    • ±â¾÷ °³¿ä
    • Á¦Ç° ¹× ¼­ºñ½º
    • »ç¾÷ Àü·«
    • À繫 ½ÇÀû
  • Florida Cancer Specialists & Research Institute(FCS)
    • ±â¾÷ °³¿ä
    • Á¦Ç° ¹× ¼­ºñ½º
    • »ç¾÷ Àü·«
    • À繫 ½ÇÀû
  • The Oncology Institute
    • ±â¾÷ °³¿ä
    • Á¦Ç° ¹× ¼­ºñ½º
    • »ç¾÷ Àü·«
    • À繫 ½ÇÀû
  • Community Care Physicians, PC(CCP)
    • ±â¾÷ °³¿ä
    • Á¦Ç° ¹× ¼­ºñ½º
    • »ç¾÷ Àü·«
    • À繫 ½ÇÀû

Á¦19Àå ÁÖ¿ä ÇÕº´°ú Àμö

  • Mayo Clinic Acquired A Minority Stake In Karkinos Healthcare
  • Integrated Oncology Network Acquired cCARE
  • City Of Hope Acquired Cancer Treatment Centers Of America
  • AKUMIN Inc Acquired Alliance Healthcare
  • US Oncology Network Acquired Alliance Cancer Specialists And Northwest Oncology
  • Carle Health Acquired Community Cancer Center
  • GenesisCare Acquired 21st Century Oncology

Á¦20Àå ±âȸ¿Í Àü·«

  • ¼¼°èÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå(2027³â)-°¡Àå »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ±¹°¡
  • ¼¼°èÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå(2027³â)-°¡Àå »õ·Î¿î ±âȸ¸¦ Á¦°øÇÏ´Â ºÎ¹®
  • ¼¼°èÀÇ Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå-¼ºÀå Àü·«
    • ½ÃÀå µ¿Çâ¿¡ ±âÃÊÇÑ Àü·«
    • °æÀï Àü·«

Á¦21Àå Ä¿¹Â´ÏƼ Á¾¾çÇÐ ¼­ºñ½º ½ÃÀå, °á·Ð¡¤Á¦¾ð

  • °á·Ð
  • ±ÇÀå »çÇ×
    • Á¦Ç°
    • Àå¼Ò
    • °¡°Ý

Á¦22Àå ºÎ·Ï

LYJ 23.03.22

“Community Oncology Services Global Market Opportunities And Strategies To 2032 ” from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global wood processing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest-growing market for community oncology services? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? “The community oncology services market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider community oncology services market; and compares it with other markets.

The report covers the following chapters:

  • Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the community oncology services market.
  • Key Trends - Highlights the major trends shaping the global community oncology services market. This section also highlights likely future developments in the market.
  • Global Market Size and Growth - Global historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis - Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region.
  • Market Segmentation - Contains the market values (2017-2032) and analysis for each segment by type, by cancer type and by therapy type in the market.
  • Regional Market Size and Growth - Regional market size (2022), historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities and Strategies

This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

  • Conclusions And Recommendations

This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for community oncology services in terms of product/service offerings, geographic expansion, marketing strategies and target group.

  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Type: Small Community Oncology Clinics; Medium Community Oncology Clinics; Large Community Oncology Clinics

2) By Cancer Type: Breast Cancer; Lung Cancer; Kidney Cancer; Ovarian Cancer; Prostate Cancer; Skin Cancer; Pancreatic Cancer; Blood Cancer; Colorectal Cancer; Other Cancer Types

3) By Therapy Type: Medical Oncology; Radiation Oncology; Surgical Oncology; Other Therapies

Companies Mentioned: The US Oncology Network; OneOncology; Florida Cancer Specialists & Research Institute (FCS); The Oncology Institute; Community Care Physicians, P.C. (CCP)

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; community oncology services market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Table Of Contents

3. List Of Figures

4. List Of Tables

5. Report Structure

6. Introduction and Market Characteristics

  • 6.1. General Market Definition
  • 6.2. Summary
  • 6.3. Community Oncology Services Market Definition And Segmentations
  • 6.4. Market Segmentation By Type
    • 6.4.1. Small Community Oncology Clinics
    • 6.4.2. Medium Community Oncology Clinics
    • 6.4.3. Large Community Oncology Clinics
  • 6.5. Market Segmentation By Cancer Type
    • 6.5.1. Breast Cancer
    • 6.5.2. Lung Cancer
    • 6.5.3. Kidney Cancer
    • 6.5.4. Ovarian Cancer
    • 6.5.5. Prostate Cancer
    • 6.5.6. Skin Cancer
    • 6.5.7. Pancreatic Cancer
    • 6.5.8. Blood Cancer
    • 6.5.9. Colorectal Cancer
    • 6.5.10. Other Cancer Types
  • 6.6. Market Segmentation By Therapy Type
    • 6.6.1. Medical Oncology
    • 6.6.2. Radiation Oncology
    • 6.6.3. Surgical Oncology
    • 6.6.4. Other Therapies

7. Major Market Trends

  • 7.1. Focus On Providing Telehealth Services
  • 7.2. Increasing Investments
  • 7.3. Partnerships And Collaborations
  • 7.4. Individualized Service Plans
  • 7.5. Technological Advancements
  • 7.6. Mergers And Acquisitions

8. Global Market Size and Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, 2017 - 2022, Value ($ Million)
    • 8.2.1. Market Drivers 2017 - 2022
    • 8.2.2. Market Restraints 2017 - 2022
  • 8.3. Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
    • 8.3.1. Market Drivers 2022 - 2027
    • 8.3.2. Market Restraints 2022 - 2027

9. Global Community Oncology Services Market Segmentation

  • 9.1. Global Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 9.2. Global Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 9.3. Global Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

10. Community Oncology Services Market, Regional and Country Analysis

  • 10.1. Global Community Oncology Services Market, By Region, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 10.2. Global Community Oncology Services Market, By Country, Historic and Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

11. Asia-Pacific Market

  • 11.1. Summary
  • 11.2. Market Overview
    • 11.2.1. Region Information
    • 11.2.2. Market Information
    • 11.2.3. Background Information
    • 11.2.4. Government Initiatives
    • 11.2.5. Regulations
    • 11.2.6. Regulatory Bodies
    • 11.2.7. Major Associations
    • 11.2.8. Taxes Levied
    • 11.2.9. Corporate Tax Structure
    • 11.2.10. Investments
    • 11.2.11. Major Companies
  • 11.3. Asia-Pacific Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 11.4. Asia-Pacific Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 11.5. Asia-Pacific Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.6. Asia-Pacific Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.7. Asia-Pacific Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.8. Asia-Pacific Community Oncology Services Market: Country Analysis
  • 11.9. China Market
  • 11.10. Summary
  • 11.11. Market Overview
    • 11.11.1. Country Information
    • 11.11.2. Market Information
    • 11.11.3. Background Information
    • 11.11.4. Government Initiatives
    • 11.11.5. Regulations
    • 11.11.6. Regulatory Bodies
    • 11.11.7. Major Associations
    • 11.11.8. Taxes Levied
    • 11.11.9. Corporate Tax Structure
    • 11.11.10. Investments
    • 11.11.11. Major Companies
  • 11.12. China Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 11.13. China Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 11.14. China Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.15. China Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.16. China Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.17. India Market
  • 11.18. India Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 11.19. India Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 11.20. India Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.21. India Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.22. India Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.23. Japan Market
  • 11.24. Japan Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 11.25. Japan Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 11.26. Japan Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.27. Japan Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.28. Japan Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.29. Australia Market
  • 11.30. Australia Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 11.31. Australia Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 11.32. Australia Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.33. Australia Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.34. Australia Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.35. Indonesia Market
  • 11.36. Indonesia Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 11.37. Indonesia Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 11.38. Indonesia Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.39. Indonesia Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.40. Indonesia Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.41. South Korea Market
  • 11.42. South Korea Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 11.43. South Korea Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 11.44. South Korea Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.45. South Korea Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 11.46. South Korea Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

12. Western Europe Market

  • 12.1. Summary
  • 12.2. Market Overview
    • 12.2.1. Region Information
    • 12.2.2. Market Information
    • 12.2.3. Background Information
    • 12.2.4. Government Initiatives
    • 12.2.5. Regulations
    • 12.2.6. Regulatory Bodies
    • 12.2.7. Major Associations
    • 12.2.8. Taxes Levied
    • 12.2.9. Corporate Tax Structure
    • 12.2.10. Investments
    • 12.2.11. Major Companies
  • 12.3. Western Europe Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 12.4. Western Europe Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 12.5. Western Europe Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.6. Western Europe Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.7. Western Europe Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.8. Western Europe Community Oncology Services Market: Country Analysis
  • 12.9. UK Market
  • 12.10. UK Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 12.11. UK Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 12.12. UK Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.13. UK Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.14. UK Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.15. Germany Market
  • 12.16. Germany Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 12.17. Germany Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 12.18. Germany Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.19. Germany Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.20. Germany Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.21. France Market
  • 12.22. France Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 12.23. France Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 12.24. France Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.25. France Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 12.26. France Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

13. Eastern Europe Market

  • 13.1. Summary
  • 13.2. Market Overview
    • 13.2.1. Region Information
    • 13.2.2. Market Information
    • 13.2.3. Background Information
    • 13.2.4. Government Initiatives
    • 13.2.5. Regulations
    • 13.2.6. Regulatory Bodies
    • 13.2.7. Major Associations
    • 13.2.8. Taxes Levied
    • 13.2.9. Corporate Tax Structure
    • 13.2.10. Investments
    • 13.2.11. Major Companies
  • 13.3. Eastern Europe Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 13.4. Eastern Europe Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 13.5. Eastern Europe Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.6. Eastern Europe Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.7. Eastern Europe Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.8. Eastern Europe Community Oncology Services Market: Country Analysis
  • 13.9. Russia Market
  • 13.10. Russia Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 13.11. Russia Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 13.12. Russia Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.13. Russia Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 13.14. Russia Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

14. North America Market

  • 14.1. Summary
  • 14.2. Market Overview
    • 14.2.1. Region Information
    • 14.2.2. Market Information
    • 14.2.3. Background Information
    • 14.2.4. Government Initiatives
    • 14.2.5. Regulations
    • 14.2.6. Regulatory Bodies
    • 14.2.7. Major Associations
    • 14.2.8. Taxes Levied
    • 14.2.9. Corporate Tax Structure
    • 14.2.10. Investments
    • 14.2.11. Major Companies
  • 14.3. North America Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 14.4. North America Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 14.5. North America Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 14.6. North America Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 14.7. North America Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 14.8. North America Community Oncology Services Market: Country Analysis
  • 14.9. USA Market
  • 14.10. Summary
  • 14.11. Market Overview
    • 14.11.1. Country Information
    • 14.11.2. Market Information
    • 14.11.3. Background Information
    • 14.11.4. Government Initiatives
    • 14.11.5. Regulations
    • 14.11.6. Regulatory Bodies
    • 14.11.7. Major Associations
    • 14.11.8. Taxes Levied
    • 14.11.9. Corporate Tax Structure
    • 14.11.10. Investments
    • 14.11.11. Major Companies
  • 14.12. USA Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 14.13. USA Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 14.14. USA Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 14.15. USA Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 14.16. USA Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

15. South America Market

  • 15.1. Summary
  • 15.2. Market Overview
    • 15.2.1. Region Information
    • 15.2.2. Market Information
    • 15.2.3. Background Information
    • 15.2.4. Government Initiatives
    • 15.2.5. Regulations
    • 15.2.6. Regulatory Bodies
    • 15.2.7. Major Associations
    • 15.2.8. Taxes Levied
    • 15.2.9. Corporate Tax Structure
    • 15.2.10. Investments
    • 15.2.11. Major Companies
  • 15.3. South America Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 15.4. South America Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 15.5. South America Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 15.6. South America Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 15.7. South America Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 15.8. South America Community Oncology Services Market: Country Analysis
  • 15.9. Brazil Market
  • 15.10. Brazil Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 15.11. Brazil Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 15.12. Brazil Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 15.13. Brazil Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 15.14. Brazil Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

16. Middle East Market

  • 16.1. Summary
  • 16.2. Market Overview
    • 16.2.1. Region Information
    • 16.2.2. Market Information
    • 16.2.3. Background Information
    • 16.2.4. Government Initiatives
    • 16.2.5. Regulations
    • 16.2.6. Regulatory Bodies
    • 16.2.7. Major Associations
    • 16.2.8. Taxes Levied
    • 16.2.9. Corporate Tax Structure
    • 16.2.10. Investments
    • 16.2.11. Major Companies
  • 16.3. Middle East Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 16.4. Middle East Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 16.5. Middle East Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.6. Middle East Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 16.7. Middle East Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

17. Africa Market

  • 17.1. Summary
  • 17.2. Market Overview
    • 17.2.1. Region Information
    • 17.2.2. Market Information
    • 17.2.3. Background Information
    • 17.2.4. Government Initiatives
    • 17.2.5. Regulations
    • 17.2.6. Regulatory Bodies
    • 17.2.7. Major Associations
    • 17.2.8. Taxes Levied
    • 17.2.9. Corporate Tax Structure
    • 17.2.10. Investments
    • 17.2.11. Major Companies
  • 17.3. Africa Community Oncology Services Market, Historic Market Growth, 2017 - 2022, Value ($ Million)
  • 17.4. Africa Community Oncology Services Market, Forecast Market Growth, 2022 - 2027, 2032F Value ($ Million)
  • 17.5. Africa Community Oncology Services Market, Segmentation By Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 17.6. Africa Community Oncology Services Market, Segmentation By Cancer Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)
  • 17.7. Africa Community Oncology Services Market, Segmentation By Therapy Type, Historic And Forecast, 2017 - 2022, 2027F, 2032F, Value ($ Million)

18. Competitive Landscape And Company Profiles

  • 18.1. Company Profiles
  • 18.2. The US Oncology Network
    • 18.2.1. Company Overview
    • 18.2.2. Products And Services
    • 18.2.3. Business Strategy
    • 18.2.4. Financial Overview
  • 18.3. OneOncology
    • 18.3.1. Company Overview
    • 18.3.2. Products And Services
    • 18.3.3. Business Strategy
    • 18.3.4. Financial Overview
  • 18.4. Florida Cancer Specialists & Research Institute (FCS)
    • 18.4.1. Company Overview
    • 18.4.2. Products And Services
    • 18.4.3. Business Strategy
    • 18.4.4. Financial Overview
  • 18.5. The Oncology Institute
    • 18.5.1. Company Overview
    • 18.5.2. Products And Services
    • 18.5.3. Business Strategy
    • 18.5.4. Financial Overview
  • 18.6. Community Care Physicians, P.C. (CCP)
    • 18.6.1. Company Overview
    • 18.6.2. Products And Services
    • 18.6.3. Business Strategy
    • 18.6.4. Financial Overview

19. Key Mergers and Acquisitions

  • 19.1. Mayo Clinic Acquired A Minority Stake In Karkinos Healthcare
  • 19.2. Integrated Oncology Network Acquired cCARE
  • 19.3. City Of Hope Acquired Cancer Treatment Centers Of America
  • 19.4. AKUMIN Inc Acquired Alliance Healthcare
  • 19.5. US Oncology Network Acquired Alliance Cancer Specialists And Northwest Oncology
  • 19.6. Carle Health Acquired Community Cancer Center
  • 19.7. GenesisCare Acquired 21st Century Oncology

20. Opportunities And Strategies

  • 20.1. Global Community Oncology Services Market In 2027 - Countries Offering Most New Opportunities
  • 20.2. Global Community Oncology Services Market In 2027 - Segments Offering Most New Opportunities
  • 20.3. Global Community Oncology Services Market In 2027 - Growth Strategies
    • 20.3.1. Market Trend Based Strategies
    • 20.3.2. Competitor Strategies

21. Community Oncology Services Market, Conclusions And Recommendations

  • 21.1. Conclusions
  • 21.2. Recommendations
    • 21.2.1. Product
    • 21.2.2. Place
    • 21.2.3. Price

22. Appendix

  • 22.1. Market Data Sources
  • 22.2. Research Methodology
  • 22.3. Currencies
  • 22.4. The Business Research Company
  • 22.5. Copyright and Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦